Nano-X Imaging Ltd. (NNOX)
NASDAQ:NNOX
Want to see NNOX full AI Analyst Report?
NNOX Stock Chart & Stats
$1.72
-$0.69(-7.28%)
At close: 4:00 PM EST
$1.72
-$0.69(-7.28%)
Day’s Range― - ―
52-Week Range$1.59 - $5.69
Previous CloseN/A
Volume2.46M
Average Volume (3M)1.23M
Market Cap
$125.96M
Enterprise Value$78.40M
Total Cash (Recent Filing)$59.61M
Total Debt (Recent Filing)$7.85M
Price to Earnings (P/E)―
Beta1.42
Next Earnings
Jun 25, 2026EPS Estimate
-0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.15
Shares Outstanding69,590,225
10 Day Avg. Volume1,122,369
30 Day Avg. Volume1,229,195
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)1.30
Price to Sales (P/S)13.93
P/FCF Ratio-4.03
Enterprise Value/Market Cap0.62
Enterprise Value/Revenue6.02
Enterprise Value/Gross Profit-6.13
Enterprise Value/Ebitda-1.60
Forecast
1Y Price Target
$6.00Price Target Upside248.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.66
Revenue Forecast (FY)$30.75M
Bulls Say, Bears Say
Bulls Say
Recurring Service Revenue ModelA service-oriented, per-scan/subscription and software revenue model creates durable, recurring revenue potential versus one-time hardware sales. Over 2–6 months this supports more predictable top-line growth and customer lock-in as deployments scale and software/reading services mature.
Large Distribution Frameworks & PipelineMulti-year distribution frameworks and a 360–400 system pipeline provide meaningful revenue visibility and commercial leverage if conversions execute. Structural impact: committed channel agreements create scale opportunities for recurring services and software monetization as placements transition from demo to active use.
Low Leverage And Near-term LiquidityLow debt and a cash balance supplemented by recent equity proceeds preserve financial flexibility while commercialization ramps. This balance-sheet strength supports continued R&D, regulatory work and deployments over the next several months without immediate refinancing pressure.
Bears Say
Negative Gross Profit & Cash BurnConsistent negative gross profit and substantial operating/free cash outflows indicate structural unit-economics problems and ongoing dependence on external funding. Until deployment economics and gross margins materially improve, the company will face durable cash-burn and dilution risk over the coming quarters.
Restructuring, Impairment & Manufacturing RiskA material impairment and manufacturing restructuring signal execution and cost-base challenges. Moving to outsourced production can reduce OpEx long-term but introduces supplier reliance, transition costs and one-time write-offs that erode equity and complicate near-term margin recovery.
Negative Unit Economics On Early DeploymentsSignificant losses on early hardware deployments show negative unit economics that threaten scalability of the core product-to-service model. Persistent losses per system would undermine long-term margin sustainability and the planned shift to recurring revenues unless per-deployment costs and yield improve.
Nano-X Imaging News
NNOX FAQ
What was Nano-X Imaging Ltd.’s price range in the past 12 months?
Nano-X Imaging Ltd. lowest stock price was $1.59 and its highest was $5.69 in the past 12 months.
What is Nano-X Imaging Ltd.’s market cap?
Nano-X Imaging Ltd.’s market cap is $125.96M.
When is Nano-X Imaging Ltd.’s upcoming earnings report date?
Nano-X Imaging Ltd.’s upcoming earnings report date is Jun 25, 2026 which is in 8 days.
How were Nano-X Imaging Ltd.’s earnings last quarter?
Nano-X Imaging Ltd. released its earnings results on Apr 20, 2026. The company reported -$0.2 earnings per share for the quarter, the consensus estimate of -$0.2 by $0.
Is Nano-X Imaging Ltd. overvalued?
According to Wall Street analysts Nano-X Imaging Ltd.’s price is currently Undervalued.
Does Nano-X Imaging Ltd. pay dividends?
Nano-X Imaging Ltd. does not currently pay dividends.
What is Nano-X Imaging Ltd.’s EPS estimate?
Nano-X Imaging Ltd.’s EPS estimate is -0.19.
How many shares outstanding does Nano-X Imaging Ltd. have?
Nano-X Imaging Ltd. has 69,590,225 shares outstanding.
What happened to Nano-X Imaging Ltd.’s price movement after its last earnings report?
Nano-X Imaging Ltd. reported an EPS of -$0.2 in its last earnings report, expectations of -$0.2. Following the earnings report the stock price went down -24.386%.
Which hedge fund is a major shareholder of Nano-X Imaging Ltd.?
Currently, no hedge funds are holding shares in NNOX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nano-X Imaging Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (248.84% Upside)
$6.00 (248.84% Upside)
Blogger Sentiment
Bullish
NNOX Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 320.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 6.5%
Last 30 Days ▼ 6.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.30%
12-Months-Change
Fundamentals
Return on Equity
-47.09%
Trailing 12-Months
Asset Growth
-22.78%
Trailing 12-Months
Company Description
Nano-X Imaging Ltd.
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
NNOX Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
Balanced/Neutral — The call highlighted meaningful commercial progress: large distribution frameworks (including a 300-system Howard agreement), an expanded sales pipeline (~400 systems potential), regulatory advances, product awards, and an acquisition that immediately contributed revenue and IT capabilities. However, these operational and commercial positives are offset in the near term by significant financial headwinds: a large GAAP loss driven by a $17.5M impairment tied to a manufacturing restructuring, deteriorated non-GAAP gross margins (32% vs 9% prior), continued losses on early hardware deployments, and elevated operating expenses. Management expects a revenue inflection in the second half of 2026, but deployment timing and conversion of the pipeline into sustainable revenue remain key risks.View all NNOX earnings summariesNNOX Stock 12 Month Forecast
Average Price Target
$6.00
▲(248.84% Upside)
Technical Analysis
Ownership Overview
0.09% Insiders
2.46% Mutual Funds
6.12% Other Institutional Investors
85.01% Public Companies and
Individual Investors